Gastrointestinal stromal tumours (unresectable, metastatic) - masitinib (post imatinib): equality impact assessment - scoping
Gastrointestinal stromal tumours (unresectable, metastatic) - masitinib (post imatinib): response to consultee and commentator comments on the draft scope and provisional matrix
Gastrointestinal stromal tumours (unresectable, metastatic) - masitinib (post imatinib): final matrix
Gastrointestinal stromal tumours (unresectable, metastatic) - masitinib (post imatinib): final scope
Gastrointestinal stromal tumours (unresectable, metastatic) - masitinib (after progression with imatinib): provisional matrix (pre-referral)
Gastrointestinal stromal tumours (unresectable, metastatic) - masitinib (after progression with imatinib): draft scope (pre-referral)